A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Cancer Genetics Education Program Bookmark and Share

Cancer Genetics Education Program

The Division of Clinical Cancer Genetics at City of Hope offers educational coursesand self-teaching tools forprofessionals in the fields of cancer and cancer genetics.ThisCancer Genetics Education Program (CGEP) is supported inpart by funding fromthe NCI (IRC4CA153828-01 andIR25CA112486).
 
Dramatic advances in our understanding of the genetic basis for cancer have led to the development of new technologies and tools for genetic cancer risk assessment. The Cancer Genetics Education Program at City of Hope offers a series of comprehensive learning tools designed to enhance the education of primary care physicians and clinical oncology professionals on the topics of cancer genetics and cancer risk assessment, and their application to patient care. Through a series of educational courses, workshops, seminars, newsletters and a direct, interactive electronic communications network, professionals can be tutored in the latest information on cancer molecular genetics, the fundamentals of obtaining an adequate family history, understanding genetic cancer risk assessment, ethical and legal complexities of genetic testing, and other current/timely topics.
 
Cancer Genetics Career Development Program
City of Hope offers an innovative  Cancer Genetics Career Development Program (CGCDP) whichprovides interdisciplinary training focused on cancer genetics and cancer prevention control research. The Traineeship is open to three applicants per year.
 
Intensive Course in Cancer Risk Assessment
City of Hope's Division of Clinical Cancer Genetics offers an annual CME/CEU-accredited multi-modal intensive course to address the need for professional training in clinical cancer genetics and research collaboration for community-based clinicians.
 
Clinical Cancer Genetics Community of Practice
City of Hope CCG Community of Practice brings cancer genetics practitioners from diverse practice settings together for professional learning, enduring patient-centered support and dynamic community-based research collaborations to promote quality care and improved patient outcomes across the U.S. and internationally.

Working Group

Clinical Cancer Genetics (CCG) Working Group is a CME-accredited interdisciplinary cancer genetics case conference series conducted each week by the City of Hope clinical team. CSPPN and affiliated clinicians across the U.S. present cases from their community practices via web conferencing for discussion and recommendations on risk assessment, surveillance, risk management and identification of research eligibility for cases covering the full spectrum of hereditary cancer.

2015 Clinical Cancer Genomics Update Conference

"From Evidence to Action: Next-Generation Approaches to Cancer Risk Assessment and Research"
City of Hope Division of Clinical Cancer Genetics (CCG), in collaboration with the University of Chicago, is excited to announce our 4th annual CME/CEU-accredited clinical cancer genetics and genomics update conference. The two-day conference will be held on Friday and Saturday, February 27 and 28, 2015, at City of Hope, Cooper Auditorium, in Duarte, CA.
 
 
Registration and additional details to follow.
 
The Conference Fee Structure* is as follows:
 
                             
CCGCoP**
members:
Non-CCGCoP
members:
Physicians $200 $275
Genetic Counselors $100 $175
Nurses & other Health Professionals (NP, PA, SW) $100 $175
Industry $200 $275
Resident/Fellow $75 $125

*After 12/28/14, all fees will increase by $50.
**Affiliation with City of Hope Division of Clinical Cancer Genetics
 
Prices include breakfast and lunch on Friday and Saturday, and a fun-filled networking dinner on Friday evening!
 
A block of rooms has been secured at a rate of $132 for single occupancy and $66 for shared at the Courtyard by Marriott, Monrovia, February 26 to 28, 2015. Don’t miss out on this great rate! (Conference attendees who want to extend their stay at the hotel may contact Karen Gadsby, at  626-531-8008.)
 
The hotel’s reservation website is:  http://www.marriott.com/hotels/maps/travel/laxmr-courtyard-los-angeles-pasadena-monrovia/ (group code to follow)
 
Anyone wishing to share accommodations with another conference attendee may contact Gloria Nunez at gnunez@coh.org, no later than January 31, 2015.
 

Clinical Cancer Genetics Events Calendar

Cancer Genetics Education Program

Cancer Genetics Education Program

The Division of Clinical Cancer Genetics at City of Hope offers educational coursesand self-teaching tools forprofessionals in the fields of cancer and cancer genetics.ThisCancer Genetics Education Program (CGEP) is supported inpart by funding fromthe NCI (IRC4CA153828-01 andIR25CA112486).
 
Dramatic advances in our understanding of the genetic basis for cancer have led to the development of new technologies and tools for genetic cancer risk assessment. The Cancer Genetics Education Program at City of Hope offers a series of comprehensive learning tools designed to enhance the education of primary care physicians and clinical oncology professionals on the topics of cancer genetics and cancer risk assessment, and their application to patient care. Through a series of educational courses, workshops, seminars, newsletters and a direct, interactive electronic communications network, professionals can be tutored in the latest information on cancer molecular genetics, the fundamentals of obtaining an adequate family history, understanding genetic cancer risk assessment, ethical and legal complexities of genetic testing, and other current/timely topics.
 
Cancer Genetics Career Development Program
City of Hope offers an innovative  Cancer Genetics Career Development Program (CGCDP) whichprovides interdisciplinary training focused on cancer genetics and cancer prevention control research. The Traineeship is open to three applicants per year.
 
Intensive Course in Cancer Risk Assessment
City of Hope's Division of Clinical Cancer Genetics offers an annual CME/CEU-accredited multi-modal intensive course to address the need for professional training in clinical cancer genetics and research collaboration for community-based clinicians.
 
Clinical Cancer Genetics Community of Practice
City of Hope CCG Community of Practice brings cancer genetics practitioners from diverse practice settings together for professional learning, enduring patient-centered support and dynamic community-based research collaborations to promote quality care and improved patient outcomes across the U.S. and internationally.

Working Group

Working Group

Clinical Cancer Genetics (CCG) Working Group is a CME-accredited interdisciplinary cancer genetics case conference series conducted each week by the City of Hope clinical team. CSPPN and affiliated clinicians across the U.S. present cases from their community practices via web conferencing for discussion and recommendations on risk assessment, surveillance, risk management and identification of research eligibility for cases covering the full spectrum of hereditary cancer.

Cancer Genetics Community Link

Cancer Genetics Community Link Discussion Board

The Cancer Genetics Community Discussion Board is a Web-based discussion board for collaborative, interdisciplinary practice-based support and continuing professional learning. CCG Community of Practice members are encouraged to post and respond to case-based questions and share resources with a growing, multidisciplinary network of professionals engaged in the practice of clinical cancer genetics. Messages are posted and archived under topic-specific forums, allowing members to search for information by topic of interest.
 
Case Consultation Questions

Breast/Ovarian Cancers (Uninformative BRCA Test Results)

Breast/Ovarian Cancers (Testing)

Breast/Ovarian Cancers (Probability/Empiric Risks)

Breast/Ovarian Cancers (Risk Management)

Breast/Ovarian Cancers (Hormone Replacement Therapy)

Male Breast Cancers

Gastrointestinal Cancers (Lynch Related)

Gastrointestinal Cancers (Polyposis Syndromes)

Gastrointestinal Cancers (Non-Colorectal)

Gastrointestinal Cancers (Risk Management)

Genitourinary Cancer

Genodermatoses

Endocrine Neoplasias

Pediatric Cancers

ELSI-Ethical, Legal, Social Issues

 

Clinical Resources

Progeny/Pedigree Drawing Issues

 

Clinical Cancer Genetics Working Group

CCG Working Group Case Conferences

 

Comments/Suggestions

Suggestion/Comment Box

 

2015 Update Conference

2015 Clinical Cancer Genomics Update Conference

"From Evidence to Action: Next-Generation Approaches to Cancer Risk Assessment and Research"
City of Hope Division of Clinical Cancer Genetics (CCG), in collaboration with the University of Chicago, is excited to announce our 4th annual CME/CEU-accredited clinical cancer genetics and genomics update conference. The two-day conference will be held on Friday and Saturday, February 27 and 28, 2015, at City of Hope, Cooper Auditorium, in Duarte, CA.
 
 
Registration and additional details to follow.
 
The Conference Fee Structure* is as follows:
 
                             
CCGCoP**
members:
Non-CCGCoP
members:
Physicians $200 $275
Genetic Counselors $100 $175
Nurses & other Health Professionals (NP, PA, SW) $100 $175
Industry $200 $275
Resident/Fellow $75 $125

*After 12/28/14, all fees will increase by $50.
**Affiliation with City of Hope Division of Clinical Cancer Genetics
 
Prices include breakfast and lunch on Friday and Saturday, and a fun-filled networking dinner on Friday evening!
 
A block of rooms has been secured at a rate of $132 for single occupancy and $66 for shared at the Courtyard by Marriott, Monrovia, February 26 to 28, 2015. Don’t miss out on this great rate! (Conference attendees who want to extend their stay at the hotel may contact Karen Gadsby, at  626-531-8008.)
 
The hotel’s reservation website is:  http://www.marriott.com/hotels/maps/travel/laxmr-courtyard-los-angeles-pasadena-monrovia/ (group code to follow)
 
Anyone wishing to share accommodations with another conference attendee may contact Gloria Nunez at gnunez@coh.org, no later than January 31, 2015.
 

Clinical Cancer Genetics Events Calendar

Clinical Cancer Genetics Events Calendar

Clinical Cancer Genetics
The City of Hope Division of Clinical Cancer Genetics is committed to being a national leader in the advancement of cancer genetics, screening and prevention, through innovative patient care, research and education.

Contact Us
  • 800-826-HOPE (4673)
  • For more information about the Cancer Screening & Prevention Program, call 626-256-8662, ext. 2.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
City of Hope Breakthroughs
Get the latest in City of Hope's research, treatment and news you can use on our blog, Breakthroughs.
 
 
NEWS & UPDATES
  • Beyond the pink ribbons, special product fundraisers, and the pastel sea of color that marks October, Breast Cancer Awareness Month offers a reason to celebrate and to reflect. More than 2.8 million breast cancer survivors live in the U.S. They are survivors of the second most-common cancer in women, behind ski...
  • Gliomas, a type of tumor that grows in the brain, are very difficult to treat successfully due to their complex nature. That might not always be the case. First some background: The most aggressive and common type of primary brain tumor in adults is glioblastoma. Although the brain tumor mass can often be remov...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. The result is rashes and, sometimes, tumors, which can be mistaken for other dermatological conditions. In a smal...
  • Weighing your breast cancer risk? One study suggests a measure to consider is skirt size. A British study suggests that for each increase in skirt size every 10 years after age 25, the five-year risk of developing breast cancer postmenopause increases from one in 61 to one in 51 – a 77 percent increase in risk....
  • Runners prize medals for 5Ks and marathons. Becky Stokes has a medal she cherishes from a very different kind of race: the marathon of treatments necessary to beat her aggressive triple-negative breast cancer. Just a week ago, she completed her last radiation treatment, and danced in the hospital with the staff...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. Darakjian’s s...
  • The environment plays a role in causing cancer – this much we know. But scientists are still trying to understand what that role is, what environmental factors are in play and how precisely those factors are linked to cancer. Now City of Hope researchers have unlocked a clue as to how one carcinogen triggers ca...
  • Jonathan Yamzon, M.D., assistant clinical professor of surgery in the Division of Urology and Urologic Oncology, explains his approach to what’s known as “active surveillance” of men with prostate cancer. Patients need to be educated about their treatment options, he writes. Active surveillanc...
  • For most prostate cancer patients, surgery or radiation therapy is the initial and primary treatment against the disease. But some patients can benefit from chemotherapy and hormone therapy too, especially if there are signs of a relapse or if the cancer has spread beyond the prostate gland. Here, Cy Stein, M.D...
  • Cancer research has yielded scientific breakthroughs that offer patients more options, more hope for survival and a higher quality of life than ever before. The 14.5 million cancer patients living in the United States are living proof that cancer research saves lives. Now, in addition to the clinic, hospital an...
  • Advances in cancer treatment, built on discoveries made in the laboratory then brought to the bedside, have phenomenally changed the reality of living with a cancer diagnosis. More than any other time in history, people diagnosed with cancer are more likely to survive and to enjoy a high quality of life. Howeve...
  • While health care reform has led to an increase in the number of people signing up for health insurance, many people remain uninsured or are not taking full advantage of the health benefits they now have. Still others are finding that, although their premiums are affordable, they aren’t able to see the do...
  • Kidney cancer rates and thyroid cancer rates in adults have continued to rise year after year. Now a new study has found that incidence rates for these cancers are also increasing in children — particularly in African-American children. The study, published online this month in Pediatrics, examined childhood ca...
  • Thyroid cancer has become one of the fastest-growing cancers in the United States for both men and women. The chance of being diagnosed with the cancer has nearly doubled since 1990. This year an estimated 63,000 people will be diagnosed with thyroid cancer in the United States and nearly 1,900 people will die ...
  • Older teenagers and young adults traditionally face worse outcomes than younger children when diagnosed with brain cancer and other central nervous system tumors. A first-of-its-kind study shows why. A team of researchers from the departments of Population Sciences and Pathology at City of Hope recently examine...